Bleeding Risk and Antithrombotic Strategy in Patients with Sinus Rhythm Heart Failure with Reduced Ejection Fraction Treated with Warfarin or Aspirin

We sought to assess the performance of existing bleeding risk scores, such as HAS-BLED or OBRI, in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin. We calculated HAS-BLED and OBRI risk scores for 2,305 patients with HFrEF in SR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cardiol
Autors principals: Ye, Siqin, Cheng, Bin, Lip, Gregory Y. H., Buchsbaum, Richard, Sacco, Ralph L., Levin, Bruce, Di Tullio, Marco R., Qian, Min, Mann, Douglas L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Mohr, J.P., Graham, Susan, Labovitz, Arthur J., Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Thompson, John L.P., Homma, Shunichi
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554775/
https://ncbi.nlm.nih.gov/pubmed/26189039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2015.06.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars